par Pegram, Mark;Perez, Edith A;Piccart-Gebhart, Martine 
;Spector, Neil
Référence Clinical breast cancer, 8 Suppl 3, page (S131-S141)
Publication Publié, 2008-03
;Spector, NeilRéférence Clinical breast cancer, 8 Suppl 3, page (S131-S141)
Publication Publié, 2008-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Pegram, Mark; Perez, Edith A; Piccart-Gebhart, Martine; Spector, Neil |
| Informations sur la publication: | Clinical breast cancer, 8 Suppl 3, page (S131-S141) |
| Statut de publication: | Publié, 2008-03 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Antineoplastic Agents -- adverse effects |
| Antineoplastic Agents -- therapeutic use | |
| Brain Neoplasms -- drug therapy | |
| Brain Neoplasms -- secondary | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- pathology | |
| Clinical Trials as Topic | |
| Drug Resistance, Neoplasm -- physiology | |
| Female | |
| Heart -- drug effects | |
| Humans | |
| Neoplasm Recurrence, Local -- drug therapy | |
| Receptor, erbB-2 -- drug effects | |
| Receptor, erbB-2 -- metabolism | |
| Tumor Markers, Biological -- analysis | |
| Note générale: | Clinical Conference |
| Journal Article | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1526-8209 |
| info:pmid/18777952 |
